Bokelo Mpia

Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy.

T. Niyonsenga, F. Milord, L. Loko, 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

TRIAL OF PREDNISOLONE FOR PREVENTION OF MELARSOPROL-INDUCED ENCEPHALOPATHY IN GAMBIENSE SLEEPING SICKNESS

J. Pépin, F. Milord, C. Guern, 1989, The Lancet.

Short-course eflornithine in Gambian trypanosomiasis: a multicentre randomized controlled trial.

S. Jaffar, N. Khonde, F. Doua, 2000, Bulletin of the World Health Organization.

A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness.

N. Khonde, J. Pépin, Bokelo Mpia, 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness

F. Milord, L. Loko, L. Ethier, 1992, The Lancet.

Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness.

T Niyonsenga, T. Niyonsenga, F. Milord, 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire.

F. Meurice, F. Milord, L. Loko, 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Combination of eflornithine and melarsoprol for melarsoprol‐resistant Gambian trypanosomiasis

B. Mpia, J. Pépin, Bokelo Mpia, 2002, Tropical medicine & international health : TM & IH.

Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness.

F. Milord, L. Loko, L. Ethier, 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire.

F. Meurice, F. Milord, H. Bruneel, 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.